Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained...
34 insider purchases on record · latest filing 2023-11-13.
Insiders have also filed 27 sale transactions at LYRA.